{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T14:10:00Z","timestamp":1780668600721,"version":"3.54.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.suronc.2026.102418","type":"journal-article","created":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:55:43Z","timestamp":1775260543000},"page":"102418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of a risk adjustment scoring system for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: HIPEC-POSSUM"],"prefix":"10.1016","volume":"66","author":[{"given":"Selman","family":"Sokmen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasemin","family":"Yildirim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagla","family":"Dinler Sensoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berke","family":"Manoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Berkay","family":"Sakaoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Ellidokuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.suronc.2026.102418_bib1","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/S1470-2045(12)70210-3","article-title":"Cytoreductive surgery plus hyperthermic perioperative chemotherapy to treat peritoneal metastases from colorectal cancer: standard of care or an experimental approach?","volume":"13","author":"Sugarbaker","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.suronc.2026.102418_bib2","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1245\/s10434-025-17518-z","article-title":"National guidelines for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal malignancies: a worldwide systematic review and recommendations of strength analysis","volume":"32","author":"Tonello","year":"2025","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.suronc.2026.102418_bib3","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2025.43.16_suppl.e17579","article-title":"Evaluating the efficacy and safety of hyperthermic intraperitoneal chemotherapy (HIPEC) as an adjunct to surgery for advanced ovarian cancer: a systematic review and meta-analysis of randomized controlled trials","volume":"43","author":"Afridi","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.suronc.2026.102418_bib4","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2024.1498529","article-title":"Challenges following CRS and HIPEC surgery in cancer patients with peritoneal metastasis: a comprehensive review of clinical outcomes","volume":"11","author":"Karimi","year":"2024","journal-title":"Front. Surg."},{"issue":"2","key":"10.1016\/j.suronc.2026.102418_bib5","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.soc.2024.11.002","article-title":"Overview: challenges of treating peritoneal surface malignancies","volume":"34","author":"Chandramouli","year":"2025","journal-title":"Surg Oncol Clin N Am"},{"issue":"12","key":"10.1016\/j.suronc.2026.102418_bib6","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.ejso.2020.08.006","volume":"46","author":"H\u00fcbner","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102418_bib7","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/bjs.1800780327","article-title":"POSSUM: a scoring system for surgical audit","volume":"78","author":"Copeland","year":"1991","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2026.102418_bib8","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/bjs.1800830628","article-title":"An evaluation of the POSSUM surgical scoring system","volume":"83","author":"Whiteley","year":"1996","journal-title":"Br. J. Surg."},{"issue":"3","key":"10.1016\/j.suronc.2026.102418_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/bjs.4414","article-title":"Risk-adjusted prediction of operative mortality in oesophagogastric surgery with O-POSSUM","volume":"91","author":"Tekkis","year":"2004","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2026.102418_bib10","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/ejvs.2001.1369","article-title":"Audit and Research Committee of the Vascular Surgical Society of Great Britain and Ireland. A model for national outcome audit in vascular surgery","volume":"21","author":"Prytherch","year":"2001","journal-title":"Eur. J. Vasc. Endovasc. Surg."},{"issue":"9","key":"10.1016\/j.suronc.2026.102418_bib11","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/bjs.4430","article-title":"Development of a dedicated risk-adjustment scoring system for colorectal surgery (colorectal POSSUM)","volume":"91","author":"Tekkis","year":"2004","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.suronc.2026.102418_bib12","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1245\/s10434-022-12794-5","article-title":"Use of prognostic factors and scores in selection of patients with colorectal cancer peritoneal metastasis for cytoreductive surgery and intraperitoneal chemotherapy: results of an international survey among oncologic clinicians","volume":"30","author":"Kozman","year":"2023","journal-title":"Ann. Surg Oncol."},{"issue":"2","key":"10.1016\/j.suronc.2026.102418_bib13","doi-asserted-by":"crossref","first-page":"e100","DOI":"10.3747\/co.22.2058","article-title":"Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms","volume":"22","author":"Dub\u00e9","year":"2015","journal-title":"Curr. Oncol."},{"issue":"11","key":"10.1016\/j.suronc.2026.102418_bib14","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00134-025-08137-z","article-title":"ESICM guidelines on circulatory shock and hemodynamic monitoring 2025","volume":"51","author":"Monnet","year":"2025","journal-title":"Intensive Care Med."},{"issue":"1","key":"10.1016\/j.suronc.2026.102418_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13054-023-04327-7","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: sixth edition","volume":"27","author":"Rossaint","year":"2023","journal-title":"Crit. Care"},{"issue":"12","key":"10.1016\/j.suronc.2026.102418_bib16","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1016\/j.ejso.2020.07.041","article-title":"Guidelines for perioperative care in cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC): ERAS Society recommendations \u2013 part I","volume":"46","author":"H\u00fcbner","year":"2020","journal-title":"Eur. J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.suronc.2026.102418_bib17","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin. Pract."},{"issue":"2","key":"10.1016\/j.suronc.2026.102418_bib18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejso.2021.09.015","article-title":"Inflammatory biomarkers to predict postoperative infectious complications after cytoreductive surgery and HIPEC for peritoneal carcinomatosis","volume":"48","author":"Amroun","year":"2022","journal-title":"Eur. J. Surg. Oncol."},{"issue":"16","key":"10.1016\/j.suronc.2026.102418_bib19","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.3390\/cancers16162874","article-title":"Albumin leakage level during cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is associated with major complications","volume":"16","author":"Kim","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.suronc.2026.102418_bib20","article-title":"Morbidity and mortality after cytoreductive surgery and HIPEC in a national reference center: a six-year experience under independent evaluation","volume":"13","author":"Vilchez","year":"2024","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.suronc.2026.102418_bib21","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.3390\/curroncol31080346","article-title":"Postoperative complications result in poor oncological outcomes: what is the evidence?","volume":"31","author":"Wajekar","year":"2024","journal-title":"Curr. Oncol."},{"issue":"13","key":"10.1016\/j.suronc.2026.102418_bib22","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1245\/s10434-020-08843-6","article-title":"Implications of postoperative complications for survival after cytoreductive surgery and HIPEC: a multi-institutional analysis of the US HIPEC collaborative","volume":"27","author":"Gamboa","year":"2020","journal-title":"Ann. Surg Oncol."},{"issue":"3","key":"10.1016\/j.suronc.2026.102418_bib23","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1245\/s10434-017-6284-6","article-title":"Implications of hyperthermic intraperitoneal chemotherapy perfusion-related hyperglycemia","volume":"25","author":"Stewart","year":"2018","journal-title":"Ann. Surg Oncol."},{"issue":"6","key":"10.1016\/j.suronc.2026.102418_bib24","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.clnu.2022.04.019","article-title":"Inflammatory burden as a prognostic biomarker for cancer","volume":"41","author":"Xie","year":"2022","journal-title":"Clin. Nutr."},{"issue":"4","key":"10.1016\/j.suronc.2026.102418_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrclinonc.2017.194","article-title":"Perioperative events influence cancer recurrence risk after surgery","volume":"15","author":"Hiller","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.suronc.2026.102418_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/codi.15003","article-title":"Prognostic factors influencing survival in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for isolated colorectal peritoneal metastases: a systematic review and meta-analysis","volume":"22","author":"Narasimhan","year":"2020","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.suronc.2026.102418_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00423-023-02912-6","article-title":"Prognostic significance of the immuno-peritoneal cancer index in peritoneal metastatic patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"408","author":"Yildirim","year":"2023","journal-title":"Langenbecks Arch. Surg."},{"key":"10.1016\/j.suronc.2026.102418_bib28","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1245\/s10434-024-16485-1","article-title":"Prognostic factors of long-term survival and conditional survival analysis in PMP patients treated with CRS+HIPEC: a retrospective study of two centers","volume":"32","author":"Liang","year":"2024","journal-title":"Ann. Surg Oncol."}],"container-title":["Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426000691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960740426000691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:07:57Z","timestamp":1780664877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960740426000691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"alternative-id":["S0960740426000691"],"URL":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102418","relation":{},"ISSN":["0960-7404"],"issn-type":[{"value":"0960-7404","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of a risk adjustment scoring system for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: HIPEC-POSSUM","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.suronc.2026.102418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102418"}}